Psychopharmacology and Psychiatry Updates

265 Avsnitt

1. Tips for Treating Perimenopausal Depression

   Publicerades: 2021-11-28
2. Naltrexone, Acamprosate, and Disulfiram for Alcohol Use Disorder

   Publicerades: 2021-11-23
3. Subclinical Hypothyroidism in Depressed Adolescents

   Publicerades: 2021-11-18
4. Principles for Managing Alcohol Use Disorder

   Publicerades: 2021-11-13
5. ECT for Depressed Patients With Borderline Personality Disorder

   Publicerades: 2021-11-08
6. Assessing and Treating Alcohol Withdrawal

   Publicerades: 2021-11-03
7. Lab Tests in Psychopharmacology

   Publicerades: 2021-10-29
8. Technology-Facilitated Adherence Enhancement and Family Involvement

   Publicerades: 2021-10-24
9. Drug-Induced Hyperthermic Syndromes in Psychiatry

   Publicerades: 2021-10-19
10. How to Improve Adherence: Targeting Reasons for Nonadherence

    Publicerades: 2021-10-14
11. Esketamine: Postmarketing Safety Concerns

    Publicerades: 2021-10-09
12. Nonadherence: Adverse Drug Reactions and Measuring Perceived Side Effects With FIBSER

    Publicerades: 2021-10-04
13. Neurocovid: Pharmacologic Recommendations for Delirium Associated With COVID-19

    Publicerades: 2021-09-29
14. How to Assess Psychotropic Drug Adherence

    Publicerades: 2021-09-24
15. Citalopram for Acute and Preventive Efficacy in Bipolar Depression (CAPE-BD)

    Publicerades: 2021-09-19
16. Delirium, Catatonia, and COVID-19

    Publicerades: 2021-09-14
17. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder

    Publicerades: 2021-09-09
18. Dopamine and Depression: Clinical Considerations

    Publicerades: 2021-09-04
19. Haloperidol, Chlorpromazine, and Atypical Antipsychotics for Managing Delirium

    Publicerades: 2021-08-30
20. New Somatic Treatments for Child and Adolescent Depression

    Publicerades: 2021-08-25